Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Whole Exome Sequencing Market by Type (Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits, Whole Exome Sequencin), By Application (Correlation Research of Normal Human, Mendelian Disease and Rare Syndrome Gene Discovery, The Research of Complex Diseases, Mouse Exome Sequencing) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028-report

Global Whole Exome Sequencing Market by Type (Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits, Whole Exome Sequencin), By Application (Correlation Research of Normal Human, Mendelian Disease and Rare Syndrome Gene Discovery, The Research of Complex Diseases, Mouse Exome Sequencing) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Report ID: 170223 3300 Miscellaneous 377 238 Pages
                                          

Industry Growth Insights published a new data on “Whole Exome Sequencing Market”. The research report is titled “Whole Exome Sequencing Market research by Types (Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits, Whole Exome Sequencin), By Applications (Correlation Research of Normal Human, Mendelian Disease and Rare Syndrome Gene Discovery, The Research of Complex Diseases, Mouse Exome Sequencing), By Players/Companies Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene, Whole Exome Sequencin”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Whole Exome Sequencing Market Research Report

By Type

Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits, Whole Exome Sequencin

By Application

Correlation Research of Normal Human, Mendelian Disease and Rare Syndrome Gene Discovery, The Research of Complex Diseases, Mouse Exome Sequencing

By Companies

Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene, Whole Exome Sequencin

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2020

Historical Year

2018 to 2019 (Data from 2010 can be provided as per availability)

Forecast Year

2028

Number of Pages

238

Number of Tables & Figures

167

Customization Available

Yes, the report can be customized as per your need.


Global Whole Exome Sequencing Industry Outlook

Global Whole Exome Sequencing Market Report Segments:

The global Whole Exome Sequencing market is segmented on the basis of:

Types

Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits, Whole Exome Sequencin

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Correlation Research of Normal Human, Mendelian Disease and Rare Syndrome Gene Discovery, The Research of Complex Diseases, Mouse Exome Sequencing

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Illumina
  2. Thermo Fisher
  3. Roche
  4. Angilent
  5. Eurofins
  6. Sengenics
  7. Ambry
  8. Macrogen
  9. BGI
  10. Novo Gene
  11. Whole Exome Sequencin

Global Whole Exome Sequencing Market Overview

Highlights of The Whole Exome Sequencing Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

    1. Agilent HaloPlex
    2. Agilent SureSelect
    3. Agilent SureSelect QXT
    4. Illumina TruSeq Exome
    5. Roche Nimblegen SeqCap
    6. MYcroarray MYbaits
    7. Whole Exome Sequencin
  1. By Application:

    1. Correlation Research of Normal Human
    2. Mendelian Disease and Rare Syndrome Gene Discovery
    3. The Research of Complex Diseases
    4. Mouse Exome Sequencing
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Whole Exome Sequencing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Whole Exome Sequencing Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Whole Exome Sequencing Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Whole Exome Sequencing Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Whole Exome Sequencing Market - Supply Chain
   4.5. Global Whole Exome Sequencing Market Forecast
      4.5.1. Whole Exome Sequencing Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Whole Exome Sequencing Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Whole Exome Sequencing Market Absolute $ Opportunity

5. Global Whole Exome Sequencing Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Whole Exome Sequencing Market Size and Volume Forecast by Type
      5.3.1. Agilent HaloPlex
      5.3.2. Agilent SureSelect
      5.3.3. Agilent SureSelect QXT
      5.3.4. Illumina TruSeq Exome
      5.3.5. Roche Nimblegen SeqCap
      5.3.6. MYcroarray MYbaits
      5.3.7. Whole Exome Sequencin
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Whole Exome Sequencing Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Whole Exome Sequencing Market Size and Volume Forecast by Application
      6.3.1. Correlation Research of Normal Human
      6.3.2. Mendelian Disease and Rare Syndrome Gene Discovery
      6.3.3. The Research of Complex Diseases
      6.3.4. Mouse Exome Sequencing
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Whole Exome Sequencing Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Whole Exome Sequencing Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Whole Exome Sequencing Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Whole Exome Sequencing Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Whole Exome Sequencing Demand Share Forecast, 2019-2026

9. North America Whole Exome Sequencing Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Whole Exome Sequencing Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Whole Exome Sequencing Market Size and Volume Forecast by Application
      9.4.1. Correlation Research of Normal Human
      9.4.2. Mendelian Disease and Rare Syndrome Gene Discovery
      9.4.3. The Research of Complex Diseases
      9.4.4. Mouse Exome Sequencing
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Whole Exome Sequencing Market Size and Volume Forecast by Type
      9.7.1. Agilent HaloPlex
      9.7.2. Agilent SureSelect
      9.7.3. Agilent SureSelect QXT
      9.7.4. Illumina TruSeq Exome
      9.7.5. Roche Nimblegen SeqCap
      9.7.6. MYcroarray MYbaits
      9.7.7. Whole Exome Sequencin
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Whole Exome Sequencing Demand Share Forecast, 2019-2026

10. Latin America Whole Exome Sequencing Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Whole Exome Sequencing Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Whole Exome Sequencing Market Size and Volume Forecast by Application
      10.4.1. Correlation Research of Normal Human
      10.4.2. Mendelian Disease and Rare Syndrome Gene Discovery
      10.4.3. The Research of Complex Diseases
      10.4.4. Mouse Exome Sequencing
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Whole Exome Sequencing Market Size and Volume Forecast by Type
      10.7.1. Agilent HaloPlex
      10.7.2. Agilent SureSelect
      10.7.3. Agilent SureSelect QXT
      10.7.4. Illumina TruSeq Exome
      10.7.5. Roche Nimblegen SeqCap
      10.7.6. MYcroarray MYbaits
      10.7.7. Whole Exome Sequencin
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Whole Exome Sequencing Demand Share Forecast, 2019-2026

11. Europe Whole Exome Sequencing Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Whole Exome Sequencing Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Whole Exome Sequencing Market Size and Volume Forecast by Application
      11.4.1. Correlation Research of Normal Human
      11.4.2. Mendelian Disease and Rare Syndrome Gene Discovery
      11.4.3. The Research of Complex Diseases
      11.4.4. Mouse Exome Sequencing
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Whole Exome Sequencing Market Size and Volume Forecast by Type
      11.7.1. gilent HaloPlex
      11.7.2. Agilent SureSelect
      11.7.3. Agilent SureSelect QXT
      11.7.4. Illumina TruSeq Exome
      11.7.5. Roche Nimblegen SeqCap
      11.7.6. MYcroarray MYbaits
      11.7.7. Whole Exome Sequencin
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Whole Exome Sequencing Demand Share, 2019-2026

12. Asia Pacific Whole Exome Sequencing Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Whole Exome Sequencing Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Whole Exome Sequencing Market Size and Volume Forecast by Application
      12.4.1. Correlation Research of Normal Human
      12.4.2. Mendelian Disease and Rare Syndrome Gene Discovery
      12.4.3. The Research of Complex Diseases
      12.4.4. Mouse Exome Sequencing
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Whole Exome Sequencing Market Size and Volume Forecast by Type
      12.7.1. Agilent HaloPlex
      12.7.2. Agilent SureSelect
      12.7.3. Agilent SureSelect QXT
      12.7.4. Illumina TruSeq Exome
      12.7.5. Roche Nimblegen SeqCap
      12.7.6. MYcroarray MYbaits
      12.7.7. Whole Exome Sequencin
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Whole Exome Sequencing Demand Share, 2019-2026

13. Middle East & Africa Whole Exome Sequencing Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Whole Exome Sequencing Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Whole Exome Sequencing Market Size and Volume Forecast by Application
      13.4.1. Correlation Research of Normal Human
      13.4.2. Mendelian Disease and Rare Syndrome Gene Discovery
      13.4.3. The Research of Complex Diseases
      13.4.4. Mouse Exome Sequencing
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Whole Exome Sequencing Market Size and Volume Forecast by Type
      13.7.1. Agilent HaloPlex
      13.7.2. Agilent SureSelect
      13.7.3. Agilent SureSelect QXT
      13.7.4. Illumina TruSeq Exome
      13.7.5. Roche Nimblegen SeqCap
      13.7.6. MYcroarray MYbaits
      13.7.7. Whole Exome Sequencin
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Whole Exome Sequencing Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Whole Exome Sequencing Market: Market Share Analysis
   14.2. Whole Exome Sequencing Distributors and Customers
   14.3. Whole Exome Sequencing Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Illumina
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Thermo Fisher
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Roche
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Angilent
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Eurofins
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Sengenics
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Ambry
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Macrogen
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. BGI
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Novo Gene
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Whole Exome Sequencin
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.

Our Trusted Clients

Contact Us